Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
599
-
Share change
-
0
-
Total reported value
-
$6,923
-
Price per share
-
$11.56
-
Number of holders
-
1
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q4 2023
As of 31 Dec 2023,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
599 shares.
The largest 10 holders included
JANE STREET GROUP, LLC, One Capital Management, LLC, Mirae Asset Global Investments Co., Ltd., Lido Advisors, LLC, Raymond James Financial Services Advisors, Inc., Portland Global Advisors LLC, UBS Group AG, IHT Wealth Management, LLC, Sightline Wealth Advisors, LLC, and OPPENHEIMER ASSET MANAGEMENT INC..
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.